Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2023 Earnings Conference Call August 1, 2023 4:30 PM ET Company Participants Susie Lisa - CFA, Senior Vice President of Investor Relations Reshma Kewalramani - President & Chief Executive Officer Stuart Arbuckle - Executive Vice President & Chief Operating Officer Charlie Wagner - Executive Vice President & Chief Financial Officer Conference Call Participants Phil Nadeau - Cowen & Company Liisa Bayko - Evercore ISI Salveen Richter - Goldman Sachs Geoff Me ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 or Registrant's telephone number, including area code (617) 341-6100 | ____________________________________________ | | | | --- | --- | --- | | Securities registered pursuant to Section 12(b) of the Act: | | | | Title of ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Goldman Sachs 44th Annual Global Healthcare Conference Call June 13, 2023 5:40 PM ET Company Participants Reshma Kewalramani - President and Chief Executive Officer Stuart Arbuckle - Chief Operating Officer Conference Call Participants Salveen Richter - Goldman Sachs Salveen Richter Great. Good afternoon, everyone. Thanks for joining us. I am Salveen Richter, I cover the biotechnology sector at Goldman Sachs. And we are really pleased to have Vertex team wit ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) BofA Securities 2023 Health Care Conference May 9, 2023 12:20 PM ET Company Participants Charlie Wagner - EVP and CFO David Altshuler - CSO and EVP, Global Research Conference Call Participants Geoff Meacham - Bank of America Geoff Meacham Welcome to the first morning of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here and we're thrilled to have Vertex Pharmaceuticals in the big room, hopefully no protesting this year. ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Susie Lisa - CFA, Senior Vice President, Investor Relations Reshma Kewalramani - President and Chief Executive Officer Stuart Arbuckle - Executive Vice President and Chief Operating Officer Charlie Wagner - Executive Vice President and Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs David Risinger - SV8 Securities Mohit Bansal - Wells Fargo Geoff ...

FIRST QUARTER 2023 FINANCIAL RESULTS ©2023 Vertex Pharmaceuticals Incorporated VERTEX MAY 1, 2023 AGENDA Introduction Susie Lisa, CFA, Senior Vice President, Investor Relations CEO Perspective and Pipeline Update Reshma Kewalramani, M.D., Chief Executive Officer and President Commercial Update Stuart Arbuckle, Executive Vice President and Chief Operating Officer Financial Results Charlie Wagner, Executive Vice President and Chief Financial Officer ©2023 Vertex Pharmaceuticals Incorporated 2 SAFE HARBOR STAT ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 000-19319 ____________________________________________ Vertex Pharma ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual Cowen Healthcare Conference March 7, 2023 2:50 PM ET Company Participants Reshma Kewalramani – President and Chief Executive Officer Charlie Wagner – Chief Financial Officer Conference Call Participants Phil Nadeau – Cowen Phil Nadeau [Call Starts Abruptly] Annual Healthcare Conference. IÂ'm Phil Nadeau, one of CowenÂ's biotech analysts, and itÂ's my pleasure to do a fireside chat with one of the bellwethers of the industry, Vertex. Happy to have ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number 000-19319 Vertex Pharmaceuticals Incorporated Registrant's telephone number, including area code (617) 341-6100 Securities registered pursuant to Se ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2022 Earnings Conference Call February 7, 2023 4:30 PM ET Company Participants Susie Lisa - Senior Vice President, Investor Relations Reshma Kewalramani - Chief Executive Officer and President Stuart Arbuckle - Chief Operating Officer Charlie Wagner - Chief Financial Officer Conference Call Participants Salveen Richter - Goldman Sachs Geoff Meacham - Bank of America Phil Nadeau - Cowen Liisa Bayko - Evercore ISI David Risinger - SVB Robyn Karnauskas - Tru ...